JAVELIN MEDLEY
12 Apr 2022
JAVELIN Medley
–
A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress with First Line PlatinumContaining Chemotherapy
–
Cancer Type | Bladder |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | - |
Sex | - |
Tumour Stream | Urothelial |
Cancer Stage | Locally Recurrent or Locally Advanced; Metastatic or Widespread |
Anticipated Start Date | - |
Anticipated End Date | - |
Hospital | Icon Cancer Centre Adelaide |
---|---|
Clinical Trial Coordinator | Sue Yeend |
sue.yeend@icon.team | |
Phone | 08 8292 2204 |
Principal Investigator | Dr Francis Parnis |
Recruitment Status | Not Yet Recruiting |
Keep up to date with the latest news and breakthroughs